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A B S T R A C T
This is the protocol for a review and there is no abstract. The objectives are as follows:
This review aims to look at the benefits and harms of LESS-N compared with the current standard of laparoscopic nephrectomy for
patients undergoing organ donation.
B A C K G R O U N D
Laparoscopic nephrectomy for benign kidney conditions was first
performed in 1991 (Clayman 1991) and laparoscopic donor
nephrectomy was successfully initiated in 1995 (Ratner 1995). In
the years since, laparoscopic nephrectomy for both benign disease
and organ donation has become the technique of choice in most
major academic centres worldwide (Canes 2010; Kaouk 2011;
Kurien 2011; Ramasamy 2011). Laparoscopic nephrectomy has
gained popularity due to decreasedmorbidity, better quality of life,
shorter hospital stay, rapid recovery period and return to normal
daily activities, better cosmetic results, and reduced postoperative
pain when compared with open nephrectomy (Kok 2006; Kurien
2011; Tugcu 2010).
Description of the condition
Simple nephrectomy procedures are being conducted for be-
nign conditions such as renovascular hypertension, chronic
pain syndromes (symptomatic acquired renal cystic disease, loin
pain/haematuria syndrome), chronic infection processes (chronic
pyelonephritis, xanthogranulomatous pyelonephritis, renal tuber-
culosis), in addition to live donor nephrectomy for kidney trans-
plantation (Walsh 2012). Because nephrectomy for transplan-
tation involves live donors, reducing postoperative morbidity is
paramount; hence, laparoscopic donor nephrectomy has become
the preferred technique in many transplant units (Walsh 2012).
Description of the intervention
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Laparoendoscopic surgery is the natural evolution of laparoscopic
surgery and has been made possible by the development of laparo-
scopic technology and instruments, in addition to increasing surgi-
cal skills (Granberg 2010). This was made possible by the develop-
ment of multichannel single ports and curved articulating instru-
ments (Canes 2010; Granberg 2010). Though various terms have
been used to describe this method, the LaparoEndoscopic Single
Site Surgery Consortium for Assessment and Research has agreed
on ’laparoendoscopic single-site surgery’ (LESS) (Tugcu 2010).
Several centres have published their results of LESS nephrectomy
(LESS-N), partial nephrectomy, pyeloplasty, and many other uro-
logical procedures (Canes 2010; Kaouk 2011; Kurien 2011; Park
2011; Tugcu 2010; Walsh 2012). Rane 2007 first described a sin-
gle port nephrectomy in 2007 which could potentially replace
standard laparoscopy.
How the intervention might work
LESS-N has been reported to be a safe and effective alternative
to laparoscopic nephrectomy with better cosmetic results and less
postoperative pain (Canes 2010; Kurien 2011; Ramasamy 2011;
Tugcu 2010). However, these advantages have only been reported
from small cohort studies. While its benefit might be greater for
cosmetic results, as shown in a survey conducted by Park 2011,
other studies of patients who underwent LESS-N compared to la-
paroscopic and open kidney surgery found that there was a signif-
icant overall benefit of LESS-N over these two modalities (Desai
2011; Kaouk 2011). However, a comparison of complications
of LESS-N versus laparoscopic nephrectomy using the modified
Clavien grading system found that LESS-N was as safe as laparo-
scopic nephrectomy with similar postoperative outcomes and low
morbidity (Ramasamy 2011).
The reduced morbidity of laparoscopic donor nephrectomy has
encouraged more potential donors to be evaluated for surgery and,
if LESS-N can be shown to safely offer significant benefits, then
more patients might benefit from the further expansion of the live
donor pool (Canes 2010). Furthermore, LESS-N can provide a
safe and effective alternative to laparoscopic nephrectomy for pa-
tients suffering from benign kidney disease such as xanthogran-
ulomatous pyelonephritis, symptomatic renal cysts, and uretero-
pelvic junction obstruction, as the resection specimen can be easily
removed through a single port (Permpongkosol 2011).
Why it is important to do this review
Though dialysis is an alternative in patients with end-stage kidney
disease, the accompanying increase in morbidity and mortality
greatly reduces the long term survival of these patients (Gajdos
2013; Suzuki 2012; Unsal 2012). Therefore, kidney transplanta-
tion is vital for these patients to allow for a potentially longer sur-
vival. To ensure live donor organs are available, methods for re-
ducing convalescence, postoperative complications, and improv-
ing cosmetic results are essential. This might lead to more willing
donors (Canes 2010; Soliman 2011). These methods include la-
paroscopic surgery and potentially more so single-site laparoscopic
surgery. The quicker recovery period and reduced pain attributed
to these surgical techniques (LESS-N and laparoscopic nephrec-
tomy) can improve the immediate postoperative quality of life for
both donor patients and those who undergo the procedure for
benign disease. Evaluating the difference between LESS-N and
laparoscopic nephrectomy in patients undergoing the procedures
for both benign disease as well as live kidney donation will indicate
which procedure is optimal in improving these factors.
O B J E C T I V E S
This review aims to look at the benefits and harms of LESS-N
compared with the current standard of laparoscopic nephrectomy
for patients undergoing organ donation.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised controlled trials (RCTs) and quasi-RCTs (RCTs
in which allocation to treatment was obtained by alternation, use
of alternate medical records, date of birth or other predictable
methods) looking at comparisons of LESS-N and laparoscopic
nephrectomy.
Types of participants
Inclusion criteria
All adult patients undergoing nephrectomy for live organ dona-
tion.
Exclusion criteria
Studies on children, patients undergoing a nephrectomy for can-
cer, or a comparison of LESS-N to any other procedure other than
laparoscopic nephrectomywill be excluded. In addition to abstract
publication and reports from meetings will also be excluded.
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Types of interventions
The intervention is LESS-N compared to laparoscopic donor
nephrectomy, conducted by the same surgical team with an ex-
perience laparoscopist (who has surpassed their learning curve for
the procedure) leading the procedure.
Types of outcome measures
1. Patient demographics (age, sex, body mass index, ASA
score)
2. Operative information (operative time, blood loss,
conversion rates, hospital stay, approach (transperitoneal or
retroperitoneal))
3. Kidney function measures (pre- and postoperative
creatinine course and glomerular filtration rate (GFR))
4. Quality of life issues (pain scores, time taken to return to
normal activity, body image satisfaction)
5. Adverse events and complications either intra- or
postoperative
6. Mortality
7. For donor nephrectomy: survival of the graft.
Primary outcomes
The primary outcomes will be the operative and postoperative
parameters compared between the two groups.
1. Operative times
2. Estimated intraoperative blood loss
3. Postoperative pain scores
4. Complications.
Secondary outcomes
Secondary outcomes will focus on the quality of life issues, kidney
function deterioration post nephrectomy, and cost analysis com-
paring between the two groups.
1. Length of hospitalisation
2. Length of time to return to normal activities
3. Blood transfusion rates
4. Conversion rates
5. Analgesic requirement postoperatively
6. Warm ischaemia time
7. Length of surgical wound, trocar size used
8. Graft survival
9. Cost analysis.
Search methods for identification of studies
Electronic searches
We will search the Cochrane Renal Group’s Specialised Register
through contact with the Trials’ Search Co-ordinator using search
terms relevant to this review. The Cochrane Renal Group’s Spe-
cialised Register contains studies identified from the following
sources.
1. Monthly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL)
2. Weekly searches of MEDLINE OVID SP
3. Handsearching of renal-related journals and the
proceedings of major renal conferences
4. Searching of the current year of EMBASE OVID SP
5. Weekly current awareness alerts for selected renal journals
6. Searches of the International Clinical Trials Register
(ICTRP) Search Portal and ClinicalTrials.gov.
Studies contained in the SpecialisedRegister are identified through
search strategies for CENTRAL,MEDLINE, andEMBASE based
on the scope of the Cochrane Renal Group. Details of these strate-
gies, as well as a list of handsearched journals, conference proceed-
ings and current awareness alerts, are available in the Specialised
Register section of information about the Cochrane Renal Group.
See Appendix 1 for search terms used in strategies for this review.
Searching other resources
1. Reference lists of clinical practice guidelines, review articles
and relevant studies.
2. Letters seeking information about unpublished or
incomplete studies to investigators known to be involved in
previous studies.
Data collection and analysis
Selection of studies
The search strategy described will be used to obtain titles and
abstracts of studies that may be relevant to the review. The titles
and abstracts will be screened independently by three authors who
will discard studies that are not applicable; however, studies and
reviews that might include relevant data or information on studies
will be retained initially. Three authors will independently assess
retrieved abstracts and, if necessary the full text, of these studies
to determine which studies satisfy the inclusion criteria.
Data extraction and management
Data extraction will be carried out independently by three authors
using standard data extraction forms. Studies reported in non-En-
glish language journals will be included if translation is possible
(e.g. via web-based translation tools) and the data can be extracted.
Where more than one publication of one study exists, reports will
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be grouped together and only the publication with the most com-
plete data will be used in the analyses. Where relevant outcomes
are only published in earlier versions these data will be used. Any
discrepancy between published versions will be highlighted. Any
disagreement will be resolved by consensus or arbitration by two
authors.
Assessment of risk of bias in included studies
The following items will be independently assessed by three au-
thors using the risk of bias assessment tool (Higgins 2011) (see
Appendix 2).
• Was there adequate sequence generation (selection bias)?
• Was allocation adequately concealed (selection bias)?
• Was knowledge of the allocated interventions adequately
prevented during the study (detection bias)?
◦ Participants and personnel
◦ Outcome assessors
• Were incomplete outcome data adequately addressed
(attrition bias)?
• Are reports of the study free of suggestion of selective
outcome reporting (reporting bias)?
• Was the study apparently free of other problems that could
put it at a risk of bias?
Measures of treatment effect
Dichotomous outcomes, such as patient demographics, complica-
tions, blood transfusion rates, conversion rates, and graft survival,
will be expressed as risk ratios (RR) with 95% confidence intervals
(CI). Continuous outcomes, such as operative times, blood loss,
postoperative pain scores, length of hospital stay, length of time to
return to normal activities, and cost analysis will be expressed as
mean difference (MD) or SMD if different scales (e.g. pain scores)
have been used.
Unit of analysis issues
Only simple parallel group designs are available for this surgical
technique comparison.
Dealing with missing data
Any further information required from the original author will
be requested by written correspondence (e.g. emailing the corre-
sponding author) and any relevant information obtained in this
manner will be included in the review. Evaluation of important
numerical data such as screened, randomised patients as well as
intention-to-treat, as-treated and per-protocol population will be
carefully performed. Attrition rates, for example drop-outs, losses
to follow-up and withdrawals will be investigated. Issues of miss-
ing data and imputation methods (e.g. last-observation-carried-
forward) will be critically appraised (Higgins 2011).
Assessment of heterogeneity
Heterogeneity will be analysed using a Chi² test on N-1 degrees
of freedom, with an alpha of 0.05 used for statistical significance
and with the I² test (Higgins 2003). I² values of 25%, 50% and
75% correspond to low, medium and high levels of heterogeneity.
Assessment of reporting biases
If possible, funnel plots will be used to assess for the potential
existence of small study bias (study effects versus study size) (
Higgins 2011).
Data synthesis
Data will be pooled using the random-effects model but the fixed-
effect model will also be used to ensure robustness of the model
chosen and susceptibility to outliers.
Subgroup analysis and investigation of heterogeneity
A subgroup analysis will be used to explore possible sources of
heterogeneity (e.g. participants, analyses of the impact of studies
with poor methodology on the final result). Heterogeneity among
participants could be related to demographics such as age and
weight. Heterogeneity in treatments could be related to experience
of the operating surgeon or assisting staff. Where possible, the risk
difference with 95% CI will be calculated for each outcome.
Sensitivity analysis
We will perform sensitivity analyses to explore the influence of the
following factors on effect size:
• repeating the analysis taking account of risk of bias
• repeating the analysis excluding any very long or large
studies to establish how much they dominate the results
• repeating the analysis excluding studies using the following
filters:
◦ diagnostic criteria
◦ language of publication
◦ source of funding (industry versus other)
◦ country
◦ conversion rate
◦ donation versus kidney disease nephrectomy
◦ extraction site
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A P P E N D I C E S
Appendix 1. Electronic search strategies
Database Search terms
CENTRAL 1. MeSH descriptor Nephrectomy, this term only
2. (laparoscopic NEAR/5 nephrectom*):ti,ab,kw in Trials
3. (laparoendoscopic single site surgery):ti,ab,kw in Trials
4. (LESS-N):ti,ab,kw in Trials
5. (LESS NEXT nephrectom*):ti,ab,kw in Trials
6. (#1 OR #2 OR #3 OR #4 OR #5)
MEDLINE 1. Nephrectomy/
2. (laparoscopic adj5 nephrectom$).tw.
3. “laparoendoscopic single site surgery”.tw.
4. “LESS-N”.tw.
5. (LESS adj nephrectom$).tw.
6. or/1-5
EMBASE 1. exp nephrectomy/
2. (laparoscopic adj5 nephrectom$).tw.
3. “laparoendoscopic single site surgery”.tw.
4. “LESS-N”.tw.
5. (LESS adj nephrectom$).tw.
6. or/1-5
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Appendix 2. Risk of bias assessment tool
Potential source of bias Assessment criteria
Random sequence generation
Selection bias (biased allocation to interventions) due to inade-
quate generation of a randomised sequence
Low risk of bias: Random number table; computer random num-
ber generator; coin tossing; shuffling cards or envelopes; throwing
dice; drawing of lots; minimization (minimization may be imple-
mented without a random element, and this is considered to be
equivalent to being random)
High risk of bias: Sequence generated by odd or even date of birth;
date (or day) of admission; sequence generated by hospital or
clinic record number; allocation by judgement of the clinician; by
preference of the participant; based on the results of a laboratory
test or a series of tests; by availability of the intervention
Unclear: Insufficient information about the sequence generation
process to permit judgement
Allocation concealment
Selection bias (biased allocation to interventions) due to inade-
quate concealment of allocations prior to assignment
Low risk of bias: Randomisation method described that would not
allow investigator/participant to know or influence intervention
group before eligible participant entered in the study (e.g. central
allocation, including telephone, web-based, and pharmacy-con-
trolled, randomisation; sequentially numbered drug containers of
identical appearance; sequentially numbered, opaque, sealed en-
velopes)
High risk of bias:Using an open random allocation schedule (e.g. a
list of random numbers); assignment envelopes were used without
appropriate safeguards (e.g. if envelopes were unsealed or non-
opaque or not sequentially numbered); alternation or rotation;
date of birth; case record number; any other explicitly unconcealed
procedure
Unclear: Randomisation stated but no information on method
used is available
Blinding of participants and personnel
Performance bias due to knowledge of the allocated interventions
by participants and personnel during the study
Low risk of bias: No blinding or incomplete blinding, but the re-
view authors judge that the outcome is not likely to be influenced
by lack of blinding; blinding of participants and key study per-
sonnel ensured, and unlikely that the blinding could have been
broken
High risk of bias: No blinding or incomplete blinding, and the
outcome is likely to be influenced by lack of blinding; blinding
of key study participants and personnel attempted, but likely that
the blinding could have been broken, and the outcome is likely
to be influenced by lack of blinding
Unclear: Insufficient information to permit judgement
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(Continued)
Blinding of outcome assessment
Detection bias due to knowledge of the allocated interventions by
outcome assessors
Low risk of bias:Noblinding of outcome assessment, but the review
authors judge that the outcome measurement is not likely to be
influenced by lack of blinding; blinding of outcome assessment
ensured, and unlikely that the blinding could have been broken
High risk of bias: No blinding of outcome assessment, and the
outcome measurement is likely to be influenced by lack of blind-
ing; blinding of outcome assessment, but likely that the blinding
could have been broken, and the outcome measurement is likely
to be influenced by lack of blinding
Unclear: Insufficient information to permit judgement
Incomplete outcome data
Attrition bias due to amount, nature or handling of incomplete
outcome data
Low risk of bias: No missing outcome data; reasons for missing
outcome data unlikely to be related to true outcome (for survival
data, censoring unlikely to be introducing bias); missing outcome
data balanced in numbers across intervention groups, with similar
reasons for missing data across groups; for dichotomous outcome
data, the proportion ofmissing outcomes comparedwith observed
event risk not enough to have a clinically relevant impact on the
intervention effect estimate; for continuous outcome data, plau-
sible effect size (difference in means or standardized difference in
means) among missing outcomes not enough to have a clinically
relevant impact on observed effect size; missing data have been
imputed using appropriate methods
High risk of bias: Reason for missing outcome data likely to be
related to true outcome, with either imbalance in numbers or rea-
sons for missing data across intervention groups; for dichotomous
outcome data, the proportion ofmissing outcomes comparedwith
observed event risk enough to induce clinically relevant bias in
intervention effect estimate; for continuous outcome data, plau-
sible effect size (difference in means or standardized difference in
means) among missing outcomes enough to induce clinically rel-
evant bias in observed effect size; ‘as-treated’ analysis done with
substantial departure of the intervention received from that as-
signed at randomisation; potentially inappropriate application of
simple imputation
Unclear: Insufficient information to permit judgement
Selective reporting
Reporting bias due to selective outcome reporting
Low risk of bias: The study protocol is available and all of the
study’s pre-specified (primary and secondary) outcomes that are of
interest in the review have been reported in the pre-specified way;
the study protocol is not available but it is clear that the published
reports include all expected outcomes, including those that were
pre-specified (convincing text of this nature may be uncommon)
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(Continued)
High risk of bias: Not all of the study’s pre-specified primary out-
comes have been reported; one or more primary outcomes is re-
ported using measurements, analysis methods or subsets of the
data (e.g. subscales) that were not pre-specified; one or more re-
ported primary outcomes were not pre-specified (unless clear jus-
tification for their reporting is provided, such as an unexpected
adverse effect); one or more outcomes of interest in the review are
reported incompletely so that they cannot be entered in a meta-
analysis; the study report fails to include results for a key outcome
that would be expected to have been reported for such a study
Unclear: Insufficient information to permit judgement
Other bias
Bias due to problems not covered elsewhere in the table
Low risk of bias: The study appears to be free of other sources of
bias.
High risk of bias: Had a potential source of bias related to the spe-
cific study design used; stopped early due to some data-dependent
process (including a formal-stopping rule); had extreme baseline
imbalance; has been claimed to have been fraudulent; had some
other problem
Unclear: Insufficient information to assess whether an important
risk of bias exists; insufficient rationale or evidence that an iden-
tified problem will introduce bias
C O N T R I B U T I O N S O F A U T H O R S
1. Draft the protocol: OMA
2. Study selection: OMA, KA,
3. Extract data from studies: OMA, KA,
4. Enter data into RevMan: OMA
5. Carry out the analysis: OMA,
6. Interpret the analysis: OMA, HK
7. Draft the final review: OMA, PC, HK
8. Disagreement resolution: PD, HK
9. Update the review: OMA
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D E C L A R A T I O N S O F I N T E R E S T
None known.
S O U R C E S O F S U P P O R T
Internal sources
• None, Not specified.
External sources
• None, Not specified.
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